IDEXX Laboratories Inc (IDXX) Shares Surge 3.4% -- What GF Score of 96 Tells Investors
gurufocus.com · 2026-10-15
On October 15, 2026, IDEXX Laboratories Inc (IDXX) shares rose 3.4% to $547.18, showing a positive performance against a 52-week range of $500.61 to $769.98. Th
TickrTrends take: IDEXX Laboratories operates in the Healthcare sector where valuation metrics often reflect both growth potential and market sentiment. The company's GF Score of 96 indicates strong fundamental quality by one analytical framework, which aligns with TickrTrends' current assessment that the stock is undervalued. For valuation-focused investors, the gap between strong quality metrics and an undervalued designation suggests potential opportunity, though such investors should examine the specific factors driving the undervaluation verdict alongside the quality score.
Read the full story at gurufocus.com →
Is IDXX undervalued? See TickrTrends' fair value analysis →